Syndecan-1 and FGF-2, but Not FGF Receptor-1, Share a Common Transport Route and Co-localize with Heparanase in the Nuclei of Mesenchymal Tumor Cells
Overview
Authors
Affiliations
Syndecan-1 forms complexes with growth factors and their cognate receptors in the cell membrane. We have previously reported a tubulin-mediated translocation of syndecan-1 to the nucleus. The transport route and functional significance of nuclear syndecan-1 is still incompletely understood. Here we investigate the sub-cellular distribution of syndecan-1, FGF-2, FGFR-1 and heparanase in malignant mesenchymal tumor cells, and explore the possibility of their coordinated translocation to the nucleus. To elucidate a structural requirement for this nuclear transport, we have transfected cells with a syndecan-1/EGFP construct or with a short truncated version containing only the tubulin binding RMKKK sequence. The sub-cellular distribution of the EGFP fusion proteins was monitored by fluorescence microscopy. Our data indicate that syndecan-1, FGF-2 and heparanase co-localize in the nucleus, whereas FGFR-1 is enriched mainly in the perinuclear area. Overexpression of syndecan-1 results in increased nuclear accumulation of FGF-2, demonstrating the functional importance of syndecan-1 for this nuclear transport. Interestingly, exogenously added FGF-2 does not follow the route taken by endogenous FGF-2. Furthermore, we prove that the RMKKK sequence of syndecan-1 is necessary and sufficient for nuclear translocation, acting as a nuclear localization signal, and the Arginine residue is vital for this localization. We conclude that syndecan-1 and FGF-2, but not FGFR-1 share a common transport route and co-localize with heparanase in the nucleus, and this transport is mediated by the RMKKK motif in syndecan-1. Our study opens a new perspective in the proteoglycan field and provides more evidence of nuclear interactions of syndecan-1.
Syndecan-1: a key player in health and disease.
Diab L, Al Kattar S, Oueini N, Hawi J, Chrabieh A, Dosh L Immunogenetics. 2024; 77(1):9.
PMID: 39688651 DOI: 10.1007/s00251-024-01366-4.
Farrugia B, Melrose J Int J Mol Sci. 2023; 24(18).
PMID: 37762403 PMC: 10531531. DOI: 10.3390/ijms241814101.
Targeting syndecan-1: new opportunities in cancer therapy.
Yang Z, Chen S, Ying H, Yao W Am J Physiol Cell Physiol. 2022; 323(1):C29-C45.
PMID: 35584326 PMC: 9236862. DOI: 10.1152/ajpcell.00024.2022.
The Role and Therapeutic Value of Syndecan-1 in Cancer Metastasis and Drug Resistance.
Guo S, Wu X, Lei T, Zhong R, Wang Y, Zhang L Front Cell Dev Biol. 2022; 9:784983.
PMID: 35118073 PMC: 8804279. DOI: 10.3389/fcell.2021.784983.
An Atlas of Heparan Sulfate Proteoglycans in the Postnatal Rat Lens.
Wishart T, Lovicu F Invest Ophthalmol Vis Sci. 2021; 62(14):5.
PMID: 34730792 PMC: 8572486. DOI: 10.1167/iovs.62.14.5.